BIOMAT Database Logo BIOMAT Database Logo

A phase II study: dose-dense carboplatin and paclitaxel as neoadjuvant chemotherapy in locally advanced cervical cancer. 2018

Vera Loizzi, and Vittoria Del Vecchio, and Francesco M Crupano, and Valentina Minicucci, and Valeria V Fumarulo, and Leonardo Resta, and Antonella Vimercati, and Stefano Bettocchi, and Ettore Cicinelli, and Gennaro Cormio
a Gynecologic Oncology Unit, Department of Biomedical Science and Human Oncology , University of Bari , Bari , Italy.

This study evaluates the efficacy and toxicity of dose-dense weekly paclitaxel and carboplatin as neoadjuvant chemotherapy in locally advanced cervical cancer (LACC). We collected 23 cases of LACC treated with weekly paclitaxel and carboplatin for nine cycles: 20 patients had complete or partial response to chemotherapy and were submitted to surgery, 3 with poor response received chemoradiation therapy. Pathologic examination showed complete response in four patients, myometrial invasion <50% in nine and >50% in seven patients, parametrial involvement in two, vaginal metastasis in one and lymphovascular space invasion, with positive margins, in another case. Despite seven patients had radiological evidence of lymph nodes involvement at diagnosis, only one had nodal metastases. Five patients showed grade 3-4 of hematologic toxicity.

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002583 Uterine Cervical Neoplasms Tumors or cancer of the UTERINE CERVIX. Cancer of Cervix,Cancer of the Cervix,Cancer of the Uterine Cervix,Cervical Cancer,Cervical Neoplasms,Cervix Cancer,Cervix Neoplasms,Neoplasms, Cervical,Neoplasms, Cervix,Uterine Cervical Cancer,Cancer, Cervical,Cancer, Cervix,Cancer, Uterine Cervical,Cervical Cancer, Uterine,Cervical Cancers,Cervical Neoplasm,Cervical Neoplasm, Uterine,Cervix Neoplasm,Neoplasm, Cervix,Neoplasm, Uterine Cervical,Uterine Cervical Cancers,Uterine Cervical Neoplasm
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000230 Adenocarcinoma A malignant epithelial tumor with a glandular organization. Adenocarcinoma, Basal Cell,Adenocarcinoma, Granular Cell,Adenocarcinoma, Oxyphilic,Adenocarcinoma, Tubular,Adenoma, Malignant,Carcinoma, Cribriform,Carcinoma, Granular Cell,Carcinoma, Tubular,Adenocarcinomas,Adenocarcinomas, Basal Cell,Adenocarcinomas, Granular Cell,Adenocarcinomas, Oxyphilic,Adenocarcinomas, Tubular,Adenomas, Malignant,Basal Cell Adenocarcinoma,Basal Cell Adenocarcinomas,Carcinomas, Cribriform,Carcinomas, Granular Cell,Carcinomas, Tubular,Cribriform Carcinoma,Cribriform Carcinomas,Granular Cell Adenocarcinoma,Granular Cell Adenocarcinomas,Granular Cell Carcinoma,Granular Cell Carcinomas,Malignant Adenoma,Malignant Adenomas,Oxyphilic Adenocarcinoma,Oxyphilic Adenocarcinomas,Tubular Adenocarcinoma,Tubular Adenocarcinomas,Tubular Carcinoma,Tubular Carcinomas
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D012189 Retrospective Studies Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons. Retrospective Study,Studies, Retrospective,Study, Retrospective
D016190 Carboplatin An organoplatinum compound that possesses antineoplastic activity. cis-Diammine(cyclobutanedicarboxylato)platinum II,Blastocarb,CBDCA,Carboplat,Carbosin,Carbotec,Ercar,JM-8,NSC-241240,Nealorin,Neocarbo,Paraplatin,Paraplatine,Platinwas,Ribocarbo,JM 8,JM8,NSC 241240,NSC241240

Related Publications

Vera Loizzi, and Vittoria Del Vecchio, and Francesco M Crupano, and Valentina Minicucci, and Valeria V Fumarulo, and Leonardo Resta, and Antonella Vimercati, and Stefano Bettocchi, and Ettore Cicinelli, and Gennaro Cormio
Dose-dense paclitaxel/carboplatin as neo-adjuvant chemotherapy followed by radical surgery in locally advanced cervical cancer: a prospective phase II study.
March 2019, Cancer chemotherapy and pharmacology,
Vera Loizzi, and Vittoria Del Vecchio, and Francesco M Crupano, and Valentina Minicucci, and Valeria V Fumarulo, and Leonardo Resta, and Antonella Vimercati, and Stefano Bettocchi, and Ettore Cicinelli, and Gennaro Cormio
Dose-Dense Neoadjuvant Chemotherapy plus Radical Surgery in Locally Advanced Cervical Cancer: A Phase II Study.
January 2015, Oncology,
Vera Loizzi, and Vittoria Del Vecchio, and Francesco M Crupano, and Valentina Minicucci, and Valeria V Fumarulo, and Leonardo Resta, and Antonella Vimercati, and Stefano Bettocchi, and Ettore Cicinelli, and Gennaro Cormio
A phase II trial of dose-dense (biweekly) paclitaxel plus carboplatin as neoadjuvant chemotherapy for operable breast cancer.
February 2016, Breast cancer research and treatment,
Vera Loizzi, and Vittoria Del Vecchio, and Francesco M Crupano, and Valentina Minicucci, and Valeria V Fumarulo, and Leonardo Resta, and Antonella Vimercati, and Stefano Bettocchi, and Ettore Cicinelli, and Gennaro Cormio
Feasibility and safety of carboplatin plus paclitaxel as neoadjuvant chemotherapy for locally advanced cervical cancer: a pilot study.
March 2014, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine,
Vera Loizzi, and Vittoria Del Vecchio, and Francesco M Crupano, and Valentina Minicucci, and Valeria V Fumarulo, and Leonardo Resta, and Antonella Vimercati, and Stefano Bettocchi, and Ettore Cicinelli, and Gennaro Cormio
Cisplatin and vinorelbine as neoadjuvant chemotherapy in locally advanced cervical cancer: a phase II study.
January 2003, International journal of gynecological cancer : official journal of the International Gynecological Cancer Society,
Vera Loizzi, and Vittoria Del Vecchio, and Francesco M Crupano, and Valentina Minicucci, and Valeria V Fumarulo, and Leonardo Resta, and Antonella Vimercati, and Stefano Bettocchi, and Ettore Cicinelli, and Gennaro Cormio
Dose-dense Neoadjuvant Chemotherapy With Paclitaxel and Carboplatin in Cervical Cancer: Efficacy on Pathological Response.
January 2021, Anticancer research,
Vera Loizzi, and Vittoria Del Vecchio, and Francesco M Crupano, and Valentina Minicucci, and Valeria V Fumarulo, and Leonardo Resta, and Antonella Vimercati, and Stefano Bettocchi, and Ettore Cicinelli, and Gennaro Cormio
Neoadjuvant chemotherapy with weekly carboplatin and paclitaxel for locally advanced cervical carcinoma.
January 2008, International journal of gynecological cancer : official journal of the International Gynecological Cancer Society,
Vera Loizzi, and Vittoria Del Vecchio, and Francesco M Crupano, and Valentina Minicucci, and Valeria V Fumarulo, and Leonardo Resta, and Antonella Vimercati, and Stefano Bettocchi, and Ettore Cicinelli, and Gennaro Cormio
Dose-dense Paclitaxel and Carboplatin as Neoadjuvant Chemotherapy for Stage IIB/IIIA Non-small Cell Lung Cancer - A Phase II trial.
December 2021, Clinical oncology (Royal College of Radiologists (Great Britain)),
Vera Loizzi, and Vittoria Del Vecchio, and Francesco M Crupano, and Valentina Minicucci, and Valeria V Fumarulo, and Leonardo Resta, and Antonella Vimercati, and Stefano Bettocchi, and Ettore Cicinelli, and Gennaro Cormio
Dose-dense paclitaxel and carboplatin vs. conventional paclitaxel and carboplatin as neoadjuvant chemotherapy for advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer: a retrospective study.
March 2020, International journal of clinical oncology,
Vera Loizzi, and Vittoria Del Vecchio, and Francesco M Crupano, and Valentina Minicucci, and Valeria V Fumarulo, and Leonardo Resta, and Antonella Vimercati, and Stefano Bettocchi, and Ettore Cicinelli, and Gennaro Cormio
Phase II trial of paclitaxel and cisplatin as neoadjuvant chemotherapy for locally advanced gastric cancer.
May 2013, Cancer chemotherapy and pharmacology,
Copied contents to your clipboard!